Miguel Angel Dorantes, MD
Family Practice · Gonzales
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 29
- 7 carriers
- Office
- 1
Offices
1 location · Salinas Valley Memorial Healthcare System · 18 clinicians in this group
Hospitals listed: 057002 · 557461 · Salinas Valley Health Medical Center. That is not proof they admit you there this week.
Plans that list them
29 plans · 7 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Dorantes’s office at (831) 675-3601 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
29 of 29 plans
| Alignment Health Advantage PPO (PPO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Silicon (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health smartHMO (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health the ONE (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Astiva Health C-SNP WOW - NorCal (HMO C-SNP) | Astiva Health | Listed | Sep 27, 2026 |
| Astiva Health Premier Plan - NorCal (HMO) | Astiva Health | Listed | Sep 27, 2026 |
| Astiva Health Savings Plan - NorCal (HMO) | Astiva Health | Listed | Sep 27, 2026 |
| Blue Shield Inspire (HMO) | Blue Shield of California | Listed | Aug 26, 2026 |
| Central Health Classic Care Plan III (HMO) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Central Health Dual Access Plan (HMO D-SNP) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Central Health Embrace Choice Plan (HMO C-SNP) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Central Health Valor Care Plan (HMO) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Imperial Courage Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Dynamic Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Senior Value (HMO C-SNP) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| SCAN Balance (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN Classic (HMO) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN MyChoice (HMO) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN Strive (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
| AARP Medicare Advantage from UHC CA-10 (HMO-POS) | UnitedHealthcare | Listed, may be out of date | Jun 10, 2026 |
California Medical Board record
Licence A128733 · Current
Licensed to practise in California · since 2014 · expires 2027-03-31 · Autonomous University of Baja California Mexicali School of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Salinas Valley Health Medical CenterSalinas, CAAcute Care Hospital · Voluntary non-profit - Other · Has an emergency department · Birthing-friendlyPart of Salinas Valley Memorial Healthcare SystemPatients rate it 4 of 5 · 74% would definitely recommend itOverall rating: 4 of 5 starsBetter than the national rate — Clostridium Difficile (C.Diff): 0.247, Oct 2024 – Sep 2025
See every measure and the patient survey for Salinas Valley Health Medical Center
Behind the star rating — Deaths: 1 better, 7 the same, 0 worse of 8 measures. Safety: 1 better, 5 the same, 0 worse of 6 measures. Readmissions: 0 better, 9 the same, 1 worse of 10 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Clostridium Difficile (C.Diff)Infections | 0.247 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.32 (0.34 to 2.3) · 1,159 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.98 (0.68 to 1.29) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 198.42 (143.23 to 253.6) · 62 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 1.7 · 112 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 6.9 · 160 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 12.2 · 203 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 10.7 · 573 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 13 · 536 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 12.1 · 239 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.9 · 2,377 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.18 (0 to 0.37) · 7,593 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.24 (0.05 to 0.43) · 7,999 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.97 (1.83 to 6.1) · 1,428 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.7 (0.16 to 3.24) · 456 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.31 (0.87 to 3.76) · 1,325 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 9.78 (3.73 to 15.83) · 461 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.23 (1.52 to 8.95) · 453 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.65 (0.17 to 3.13) · 279 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.48 (0 to 1.11) · 6,011 cases | No different | Jul 2022 – Jun 2024 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 1.487 | No different | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 1.082 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.432 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.373 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 14.5 · 197 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 22.2 · 491 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 18.2 · 224 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 8 · 660 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | -0.3 · 569 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 18.1 · 485 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.9 (4.2 to 8.4) · 244 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 11 (8.4 to 14.3) · 244 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission for CABGUnplanned return visits | 10.9 · 86 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.3 · 158 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13.4 (9.9 to 17.9) · 197 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1.2 (0.9 to 1.5) · 489 cases | No different | Jan 2024 – Dec 2024 |
What patients said (1,383 patients answered, 16% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 3 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 2 |
| Recommend hospital | 4 |
| Room was "always" clean | 79% |
| Nurses "always" communicated well | 81% |
| Doctors "always" communicated well | 78% |
| Staff "always" explained | 66% |
| Yes, staff "did" give patients this information | 88% |
| Yes, staff "did" give patients information about help after discharge | 87% |
| Doctors "always" explained things so they could understand | 75% |
| Doctors "always" listened carefully | 76% |
| Doctors "always" treated them with courtesy and respect | 84% |
| Patients who gave a rating of "9" or "10" (high) | 73% |
| Staff "always" explained new medications | 78% |
| Nurses "always" explained things so they could understand | 78% |
| Nurses "always" listened carefully | 78% |
| Nurses "always" treated them with courtesy and respect | 88% |
| "Always" quiet at night | 46% |
| "YES", patients would definitely recommend the hospital | 74% |
| Staff "always" explained possible side effects | 53% |
| Yes, staff "did" give patients information about possible symptoms | 88% |
Original Medicare doctor bills
$8,726
Medicare paid this office $8,726 for 168 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Hepatitis b vaccine, adult dosage (3 dose schedule) | 14 | $1,172 | $69 |
| Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus and influenza | 13 | $895 | $69 |
| Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | 15 | $824 | $43 |
| Administration of hepatitis b vaccine | 14 | $583 | $34 |
| Injection of drug or substance under skin or into muscle | 19 | $429 | $12 |
See all 10 services
| Hepatitis b vaccine, adult dosage (3 dose schedule) | 14 | $1,172 | $69 |
| Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus and influenza | 13 | $895 | $69 |
| Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | 15 | $824 | $43 |
| Administration of hepatitis b vaccine | 14 | $583 | $34 |
| Injection of drug or substance under skin or into muscle | 19 | $429 | $12 |
| Imaging of retina with remote review by clinical staff | 14 | $175 | $13 |
| Automated urinalysis test | 29 | $73 | $2 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 18 | $36 | None |
| Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | 13 | $29 | None |
| Injection, ketorolac tromethamine, per 15 mg | 11 | $24 | None |
Who their Medicare patients are
168 Original Medicare patients in 2024. Average age 74 · Under 65 13% · 85 and older 11% · Women 60% · Also on Medicaid 62% · Health risk score 1.24. Above the middle of the specialty; the typical family practice clinician is at 1.13.
Conditions among them: High blood pressure 75% · Diabetes 50% · Chronic kidney disease 21% · Atrial fibrillation 15% · Depression 15% · COPD 14% · Coronary heart disease 11% · Heart failure 11% · Cancer 8% · Dementia 7% · Stroke 7%.
The office billed $53,186, Medicare allowed $10,503 and paid $8,726; for 444 services of 49 kinds; $2,814 of it was for drugs given in the office and $5,912 for care.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 168 | 444 | 74 | 1.24 | $53,186 | $8,726 |
| 2023 | 111 | 409 | 73 | 1.35 | $41,003 | $4,066 |
| 2022 | 45 | 242 | 74 | 0.98 | $20,349 | $2,097 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 5 services
| Injection of drug or substance under skin or into muscle | 21 | $511 | $10 |
| Hemoglobin a1c level | 11 | $114 | $10 |
| Injection, ketorolac tromethamine, per 15 mg | 14 | $46 | None |
| Automated urinalysis test | 20 | $44 | $2 |
| Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | 17 | $35 | None |
2022: 2 services
| Injection of drug or substance under skin or into muscle | 13 | $405 | $12 |
| Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | 12 | $36 | None |
Medicaid work
$220,239 in 2024
Medicaid paid $220,239 for 4,785 billed services this clinician did in 2024, up to 110 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Clinic visit/encounter, all-inclusive | 985 | $208,267 |
| Screening performed and negative | 304 | $6,509 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; 18-39 years | 69 | $2,367 |
| Influenza virus vaccine, trivalent (IIV3), split virus, preservative free, 0.5 mL dosage, for intramuscular use | 56 | $845 |
| Return visit (30+ min) | 703 | $714 |
| Hepatitis B vaccine (HepB), adult dosage, 3 dose schedule, for intramuscular use | 14 | $674 |
| Screening performed and positive and provision of recommendations | 21 | $479 |
| Short return visit (20+ min) | 722 | $213 |
| Short return visit | 214 | $118 |
| Pure tone audiometry (threshold); air only | 12 | $33 |
| HEMOGLOBIN | 54 | $14 |
| Bilateral quantitative screening test of visual acuity | 12 | $5 |
| 2024 | 4,785 | 21 | 110 | $220,239 |
| 2023 | 5,296 | 12 | 186 | $221,189 |
| 2022 | 5,451 | 15 | 114 | $193,457 |
| 2021 | 5,962 | 24 | 331 | $500,414 |
| 2020 | 12,532 | 25 | 385 | $648,761 |
| 2019 | 20,770 | 26 | 683 | $1,691,990 |
| 2018 | 19,955 | 23 | 764 | $1,849,789 |
See the largest Medicaid services in earlier years
2023
| Clinic visit/encounter, all-inclusive | 1,150 | $215,747 |
| Return visit (30+ min) | 923 | $1,155 |
| Influenza virus vaccine, quadrivalent (IIV4), split virus, preservative free, 0.5 mL dosage, for intramuscular use | 113 | $1,025 |
| Pure tone audiometry (threshold); air only | 118 | $968 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; adolescent (age 12 through 17 years) | 29 | $768 |
| Short return visit (20+ min) | 1,266 | $637 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; early childhood (age 1 through 4 years) | 27 | $486 |
| HEMOGLOBIN | 236 | $244 |
| Bilateral quantitative screening test of visual acuity | 113 | $155 |
| Screening for depression is documented as negative, a follow-up plan is not required | 640 | $4 |
| TOBACCO NON-USER | 540 | $0 |
| Advance Care Planning discussed and documented advance care plan or surrogate decision maker documented in the medical record (DEM) (GER, Pall Cr) | 141 | $0 |
2022
| Clinic visit/encounter, all-inclusive | 1,030 | $187,916 |
| Pure tone audiometry (threshold); air only | 98 | $951 |
| Short return visit (20+ min) | 1,482 | $884 |
| 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | 21 | $821 |
| Annual alcohol misuse screening, 5 to 15 minutes | 73 | $733 |
| Return visit (30+ min) | 451 | $580 |
| Infectious agent antigen detection by immunoassay with direct optical (ie, visual) observation; severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) | 12 | $455 |
| Infectious agent antigen detection by immunoassay with direct optical (ie, visual) observation; Influenza | 43 | $340 |
| Influenza virus vaccine, quadrivalent (IIV4), split virus, preservative free, 0.5 mL dosage, for intramuscular use | 18 | $246 |
| HEMOGLOBIN | 193 | $228 |
| Bilateral quantitative screening test of visual acuity | 96 | $167 |
| Infectious agent antigen detection by immunoassay with direct optical (ie, visual) observation; Streptococcus, group A | 23 | $133 |
2021
| Clinic visit/encounter, all-inclusive | 2,010 | $492,931 |
| Short return visit (20+ min) | 2,420 | $2,271 |
| New patient visit (30+ min) | 90 | $1,597 |
| Pure tone audiometry (threshold); air only | 187 | $1,226 |
| 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | 23 | $616 |
| Hemoglobin A1C level | 151 | $496 |
| Return visit (30+ min) | 250 | $304 |
| Infectious agent antigen detection by immunoassay with direct optical (ie, visual) observation; Influenza | 43 | $302 |
| Human Papillomavirus vaccine types 6, 11, 16, 18, 31, 33, 45, 52, 58, nonavalent (9vHPV), 2 or 3 dose schedule, for intramuscular use | 54 | $186 |
| Infectious agent antigen detection by immunoassay with direct optical (ie, visual) observation; Streptococcus, group A | 23 | $112 |
| HEMOGLOBIN | 174 | $106 |
| Hemoglobin; by copper sulfate method, non-automated | 89 | $105 |
2020
| Clinic visit/encounter, all-inclusive | 3,666 | $615,858 |
| Short return visit (20+ min) | 5,425 | $13,343 |
| Pure tone audiometry (threshold); air only | 342 | $4,044 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; late childhood (age 5 through 11 years) | 104 | $3,638 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; adolescent (age 12 through 17 years) | 56 | $3,225 |
| Human Papillomavirus vaccine types 6, 11, 16, 18, 31, 33, 45, 52, 58, nonavalent (9vHPV), 2 or 3 dose schedule, for intramuscular use | 54 | $1,491 |
| Return visit (30+ min) | 213 | $1,435 |
| Influenza virus vaccine, trivalent, live (LAIV3), for intranasal use | 259 | $1,348 |
| OFF/OP EST MAY X REQ PHY/QHP | 669 | $962 |
| Hemoglobin A1C level | 146 | $848 |
| Infectious agent antigen detection by immunoassay with direct optical (ie, visual) observation; Streptococcus, group A | 324 | $777 |
| HEMOGLOBIN | 435 | $549 |
2019
| Clinic visit/encounter, all-inclusive | 10,854 | $1,636,378 |
| Short return visit (20+ min) | 6,301 | $40,453 |
| Pure tone audiometry (threshold); air only | 422 | $3,104 |
| New patient visit (30+ min) | 114 | $2,645 |
| Infectious agent antigen detection by immunoassay with direct optical (ie, visual) observation; Streptococcus, group A | 664 | $2,156 |
| Short return visit | 152 | $1,828 |
| Return visit (30+ min) | 198 | $1,288 |
| Influenza virus vaccine, trivalent, live (LAIV3), for intranasal use | 339 | $998 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; late childhood (age 5 through 11 years) | 32 | $767 |
| Influenza virus vaccine, quadrivalent (IIV4), split virus, preservative free, 0.5 mL dosage, for intramuscular use | 170 | $562 |
| HEMOGLOBIN | 601 | $440 |
| Influenza virus vaccine, quadrivalent (IIV4), split virus, 0.5 mL dosage, for intramuscular use | 19 | $252 |
2018
| Clinic visit/encounter, all-inclusive | 12,169 | $1,771,498 |
| Short return visit (20+ min) | 4,808 | $47,294 |
| New patient visit (30+ min) | 223 | $13,733 |
| Pure tone audiometry (threshold); air only | 313 | $4,240 |
| Infectious agent antigen detection by immunoassay with direct optical (ie, visual) observation; Streptococcus, group A | 813 | $3,691 |
| Return visit (30+ min) | 249 | $3,069 |
| Hemoglobin A1C level | 146 | $1,105 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; late childhood (age 5 through 11 years) | 23 | $1,063 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; adolescent (age 12 through 17 years) | 18 | $786 |
| HEMOGLOBIN | 462 | $656 |
| Influenza virus vaccine, trivalent, live (LAIV3), for intranasal use | 51 | $409 |
| Influenza virus vaccine, trivalent (IIV3), split virus, preservative free, 0.5 mL dosage, for intramuscular use | 18 | $350 |
Drugs they prescribed that Part D paid
$440,269
Pharmacies billed $440,269 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 1% of their Part D prescriptions (36 of 4,149) in 2024. At or below the middle of the specialty; the typical family practice clinician is at 2%.
3,482 generic and 594 brand-name prescriptions · $440,269 in drug cost · 61 antibiotic prescriptions to 39 people · 11 antipsychotic prescriptions to people over 65.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Jardiance | 127 | $103,102 | $812 |
| Ozempic | 77 | $74,044 | $962 |
| Trulicity | 43 | $40,540 | $943 |
| Mounjaro | 33 | $31,639 | $959 |
| Eliquis | 32 | $23,740 | $742 |
See all 79 drugs
| Jardiance | 127 | $103,102 | $812 |
| Ozempic | 77 | $74,044 | $962 |
| Trulicity | 43 | $40,540 | $943 |
| Mounjaro | 33 | $31,639 | $959 |
| Eliquis | 32 | $23,740 | $742 |
| Januvia | 23 | $18,969 | $825 |
| Tradjenta | 18 | $15,747 | $875 |
| Entresto | 11 | $8,592 | $781 |
| Basaglar Kwikpen U-100 | 12 | $3,055 | $255 |
| Atorvastatin | 336 | $2,767 | $8 |
| Levothyroxine | 111 | $2,338 | $21 |
| Losartan | 224 | $2,240 | $10 |
| Albuterol Sulfate Hfa | 48 | $1,848 | $38 |
| Metformin | 196 | $1,474 | $8 |
| Chlorthalidone | 65 | $1,227 | $19 |
| Omeprazole | 85 | $1,141 | $13 |
| Tamsulosin | 78 | $1,119 | $14 |
| Lisinopril | 137 | $1,117 | $8 |
| Gabapentin | 83 | $994 | $12 |
| Pantoprazole | 82 | $994 | $12 |
| Estradiol | 11 | $967 | $88 |
| Rosuvastatin | 65 | $950 | $15 |
| Losartan-Hydrochlorothiazide | 54 | $854 | $16 |
| Nifedipine Er | 38 | $835 | $22 |
| Duloxetine | 17 | $819 | $48 |
| Potassium Chloride | 48 | $818 | $17 |
| Amlodipine Besylate | 153 | $815 | $5 |
| Mirtazapine | 34 | $731 | $22 |
| Simvastatin | 78 | $679 | $9 |
| Ultra-Fine Mini Pen Needle | 12 | $636 | $53 |
| Metoprolol | 82 | $618 | $8 |
| Montelukast | 53 | $564 | $11 |
| Metoprolol | 34 | $526 | $15 |
| Diclofenac | 24 | $497 | $21 |
| Doxazosin Mesylate | 29 | $489 | $17 |
| Fluticasone Propionate | 47 | $488 | $10 |
| Clotrimazole | 19 | $471 | $25 |
| Furosemide | 58 | $420 | $7 |
| Quetiapine | 11 | $417 | $38 |
| Alendronate | 49 | $401 | $8 |
| Celecoxib | 15 | $389 | $26 |
| Hydroxyzine | 41 | $381 | $9 |
| Carvedilol | 47 | $380 | $8 |
| Hydrochlorothiazide | 49 | $378 | $8 |
| Lisinopril-Hydrochlorothiazide | 35 | $374 | $11 |
| Escitalopram | 28 | $341 | $12 |
| Finasteride | 23 | $334 | $15 |
| Sertraline | 17 | $330 | $19 |
| Ezetimibe | 14 | $322 | $23 |
| Fluconazole | 15 | $306 | $20 |
| Trazodone | 26 | $303 | $12 |
| Testosterone Cypionate | 12 | $281 | $23 |
| Levetiracetam | 15 | $273 | $18 |
| Pioglitazone | 17 | $256 | $15 |
| Glipizide | 15 | $237 | $16 |
| Triamcinolone Acetonide | 30 | $217 | $7 |
| Pregabalin | 11 | $213 | $19 |
| Sucralfate | 11 | $210 | $19 |
| Meclizine | 26 | $204 | $8 |
| Benazepril | 16 | $203 | $13 |
| Allopurinol | 20 | $195 | $10 |
| Hydralazine | 17 | $182 | $11 |
| Metformin Hcl Er | 19 | $175 | $9 |
| Glimepiride | 12 | $169 | $14 |
| Citalopram Hbr | 32 | $156 | $5 |
| Mupirocin | 11 | $146 | $13 |
| Ibuprofen | 30 | $134 | $4 |
| Sumatriptan | 17 | $120 | $7 |
| Fenofibrate | 13 | $100 | $8 |
| Tramadol | 26 | $87 | $3 |
| Sulfamethoxazole-Trimethoprim | 25 | $73 | $3 |
| Naproxen | 11 | $69 | $6 |
| Donepezil | 12 | $59 | $5 |
| Buspirone | 12 | $57 | $5 |
| Meloxicam | 21 | $53 | $3 |
| Fluoxetine | 11 | $51 | $5 |
| Prednisone | 15 | $36 | $2 |
| Ssd | 11 | $17 | $2 |
| Zolpidem | 11 | $4 | $0 |
Year by year
| 2024 | 4,149 | 558 | 1% (36) | 14% | $440,269 |
| 2023 | 2,584 | 392 | 1% (37) | 13% | $283,616 |
| 2022 | 1,114 | 240 | 1% (15) | 9% | $84,309 |
| 2021 | 822 | 130 | None | 10% | $54,213 |
| 2020 | 833 | 98 | 2% (19) | 9% | $42,550 |
| 2019 | 697 | 72 | None | None | $55,925 |
| 2018 | 907 | 81 | 2% (20) | 15% | $61,212 |
| 2017 | 831 | 96 | None | 15% | $52,963 |
| 2016 | 574 | 76 | None | None | $29,431 |
| 2015 | 386 | 68 | None | None | $17,816 |
| 2014 | 127 | 31 | 11% (14) | None | $4,005 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 60 drugs
| Jardiance | 62 | $56,665 | $914 |
| Ozempic | 30 | $35,006 | $1,167 |
| Trulicity | 24 | $23,835 | $993 |
| Eliquis | 11 | $13,757 | $1,251 |
| Tradjenta | 15 | $10,169 | $678 |
| Novolog Flexpen | 27 | $9,569 | $354 |
| Atorvastatin | 166 | $4,840 | $29 |
| Basaglar Kwikpen U-100 | 11 | $3,968 | $361 |
| Losartan | 137 | $3,471 | $25 |
| Metformin | 124 | $1,825 | $15 |
| Tamsulosin | 45 | $1,730 | $38 |
| Amlodipine Besylate | 107 | $1,677 | $16 |
| Levothyroxine | 56 | $1,572 | $28 |
| Lisinopril | 85 | $1,539 | $18 |
| Chlorthalidone | 59 | $1,389 | $24 |
| Pantoprazole | 63 | $1,322 | $21 |
| Gabapentin | 59 | $1,247 | $21 |
| Doxazosin Mesylate | 26 | $1,212 | $47 |
| Celecoxib | 17 | $1,137 | $67 |
| Duloxetine | 24 | $1,127 | $47 |
| Omeprazole | 47 | $1,035 | $22 |
| Mirtazapine | 26 | $960 | $37 |
| Metoprolol | 68 | $921 | $14 |
| Montelukast | 38 | $879 | $23 |
| Fluticasone Propionate | 40 | $873 | $22 |
| Simvastatin | 38 | $807 | $21 |
| Ventolin Hfa | 12 | $744 | $62 |
| Rosuvastatin | 33 | $719 | $22 |
| Nifedipine Er | 13 | $718 | $55 |
| Losartan-Hydrochlorothiazide | 30 | $700 | $23 |
| Diclofenac | 15 | $678 | $45 |
| Carvedilol | 35 | $640 | $18 |
| Albuterol Sulfate Hfa | 13 | $594 | $46 |
| Alendronate | 33 | $551 | $17 |
| Divalproex | 15 | $461 | $31 |
| Lisinopril-Hydrochlorothiazide | 18 | $447 | $25 |
| Potassium Chloride | 20 | $427 | $21 |
| Glimepiride | 19 | $427 | $22 |
| Finasteride | 13 | $416 | $32 |
| Furosemide | 33 | $399 | $12 |
| Sertraline | 21 | $389 | $19 |
| Triamcinolone Acetonide | 33 | $355 | $11 |
| Fluconazole | 17 | $334 | $20 |
| Hydroxyzine | 30 | $328 | $11 |
| Donepezil | 16 | $318 | $20 |
| Allopurinol | 11 | $241 | $22 |
| Tramadol | 25 | $233 | $9 |
| Ibuprofen | 23 | $222 | $10 |
| Trazodone | 17 | $172 | $10 |
| Hydrochlorothiazide | 31 | $167 | $5 |
| Paroxetine | 11 | $149 | $14 |
| Clopidogrel | 11 | $144 | $13 |
| Zolpidem | 14 | $128 | $9 |
| Meclizine | 13 | $121 | $9 |
| Naproxen | 12 | $113 | $9 |
| Ondansetron | 11 | $106 | $10 |
| Sulfamethoxazole-Trimethoprim | 17 | $71 | $4 |
| Cephalexin | 12 | $69 | $6 |
| Prednisone | 21 | $68 | $3 |
| Alprazolam | 11 | $43 | $4 |
2022: 26 drugs
| Jardiance | 23 | $17,280 | $751 |
| Trulicity | 12 | $12,459 | $1,038 |
| Atorvastatin | 78 | $1,307 | $17 |
| Losartan | 69 | $1,180 | $17 |
| Metformin | 69 | $742 | $11 |
| Levothyroxine | 24 | $620 | $26 |
| Chlorthalidone | 29 | $568 | $20 |
| Omeprazole | 31 | $505 | $16 |
| Pantoprazole | 32 | $457 | $14 |
| Tamsulosin | 20 | $444 | $22 |
| Lisinopril | 40 | $418 | $10 |
| Hydroxyzine | 31 | $374 | $12 |
| Montelukast | 20 | $313 | $16 |
| Fluticasone Propionate | 13 | $291 | $22 |
| Simvastatin | 18 | $279 | $16 |
| Mirtazapine | 12 | $248 | $21 |
| Triamcinolone Acetonide | 25 | $156 | $6 |
| Ibuprofen | 19 | $155 | $8 |
| Amlodipine Besylate | 34 | $155 | $5 |
| Metoprolol | 27 | $153 | $6 |
| Cephalexin | 12 | $98 | $8 |
| Hydrochlorothiazide | 17 | $92 | $5 |
| Sulfamethoxazole-Trimethoprim | 16 | $79 | $5 |
| Furosemide | 14 | $69 | $5 |
| Prednisone | 16 | $67 | $4 |
| Tramadol | 11 | $25 | $2 |
2021: 17 drugs
| Chlorthalidone | 31 | $779 | $25 |
| Omeprazole | 36 | $633 | $18 |
| Levothyroxine | 29 | $626 | $22 |
| Atorvastatin | 28 | $601 | $21 |
| Albuterol Sulfate Hfa | 15 | $599 | $40 |
| Metformin | 59 | $456 | $8 |
| Losartan | 32 | $445 | $14 |
| Lisinopril | 51 | $351 | $7 |
| Amlodipine Besylate | 39 | $309 | $8 |
| Pantoprazole | 13 | $287 | $22 |
| Glimepiride | 23 | $168 | $7 |
| Hydrochlorothiazide | 22 | $138 | $6 |
| Metoprolol | 22 | $128 | $6 |
| Hydroxyzine | 17 | $121 | $7 |
| Montelukast | 11 | $121 | $11 |
| Triamcinolone Acetonide | 15 | $60 | $4 |
| Simvastatin | 14 | $51 | $4 |
2020: 19 drugs
| Chlorthalidone | 44 | $1,384 | $31 |
| Atorvastatin | 43 | $655 | $15 |
| Losartan | 33 | $522 | $16 |
| Levothyroxine | 16 | $448 | $28 |
| Albuterol Sulfate Hfa | 11 | $445 | $40 |
| Lisinopril | 61 | $426 | $7 |
| Omeprazole | 29 | $374 | $13 |
| Metformin | 42 | $341 | $8 |
| Glimepiride | 24 | $285 | $12 |
| Sertraline | 22 | $235 | $11 |
| Amlodipine Besylate | 28 | $202 | $7 |
| Gabapentin | 11 | $153 | $14 |
| Montelukast | 15 | $153 | $10 |
| Cyclobenzaprine | 17 | $138 | $8 |
| Metoprolol | 15 | $112 | $7 |
| Simvastatin | 18 | $109 | $6 |
| Hydrochlorothiazide | 12 | $72 | $6 |
| Clonazepam | 12 | $65 | $5 |
| Triamcinolone Acetonide | 12 | $62 | $5 |
2019: 15 drugs
| Chlorthalidone | 32 | $1,071 | $33 |
| Atorvastatin | 39 | $563 | $14 |
| Levothyroxine | 21 | $485 | $23 |
| Omeprazole | 25 | $390 | $16 |
| Lisinopril | 41 | $360 | $9 |
| Metformin | 29 | $281 | $10 |
| Losartan | 28 | $249 | $9 |
| Gabapentin | 17 | $228 | $13 |
| Simvastatin | 32 | $220 | $7 |
| Amlodipine Besylate | 26 | $218 | $8 |
| Glimepiride | 13 | $171 | $13 |
| Metoprolol | 17 | $156 | $9 |
| Cyclobenzaprine | 11 | $155 | $14 |
| Montelukast | 11 | $116 | $11 |
| Hydrochlorothiazide | 14 | $90 | $6 |
2018: 22 drugs
| Ventolin Hfa | 14 | $934 | $67 |
| Chlorthalidone | 27 | $913 | $34 |
| Quetiapine | 16 | $894 | $56 |
| Levothyroxine | 24 | $586 | $24 |
| Baclofen | 15 | $421 | $28 |
| Omeprazole | 48 | $408 | $9 |
| Phenobarbital | 14 | $406 | $29 |
| Montelukast | 30 | $321 | $11 |
| Sertraline | 21 | $313 | $15 |
| Metformin | 31 | $293 | $9 |
| Lisinopril | 36 | $282 | $8 |
| Simvastatin | 36 | $242 | $7 |
| Losartan | 34 | $218 | $6 |
| Gabapentin | 14 | $215 | $15 |
| Amlodipine Besylate | 32 | $211 | $7 |
| Glimepiride | 16 | $190 | $12 |
| Metoprolol | 11 | $179 | $16 |
| Ibuprofen | 15 | $128 | $9 |
| Fluticasone Propionate | 13 | $124 | $10 |
| Trazodone | 14 | $100 | $7 |
| Triamcinolone Acetonide | 15 | $55 | $4 |
| Hydrochlorothiazide | 11 | $35 | $3 |
2017: 21 drugs
| Chlorthalidone | 40 | $1,060 | $26 |
| Quetiapine | 23 | $937 | $41 |
| Phenobarbital | 20 | $621 | $31 |
| Omeprazole | 53 | $408 | $8 |
| Levothyroxine | 21 | $349 | $17 |
| Montelukast | 34 | $345 | $10 |
| Losartan | 37 | $323 | $9 |
| Atorvastatin | 16 | $309 | $19 |
| Baclofen | 14 | $239 | $17 |
| Sertraline | 17 | $238 | $14 |
| Metformin | 28 | $224 | $8 |
| Amlodipine Besylate | 27 | $191 | $7 |
| Simvastatin | 23 | $141 | $6 |
| Lisinopril | 21 | $113 | $5 |
| Trazodone | 14 | $93 | $7 |
| Ibuprofen | 13 | $87 | $7 |
| Gabapentin | 11 | $87 | $8 |
| Glimepiride | 13 | $80 | $6 |
| Azithromycin | 13 | $65 | $5 |
| Sulfamethoxazole-Trimethoprim | 11 | $63 | $6 |
| Triamcinolone Acetonide | 20 | $63 | $3 |
2016: 15 drugs
| Levothyroxine | 25 | $483 | $19 |
| Omeprazole | 50 | $355 | $7 |
| Chlorthalidone | 12 | $263 | $22 |
| Metformin | 32 | $205 | $6 |
| Simvastatin | 28 | $201 | $7 |
| Montelukast | 17 | $189 | $11 |
| Losartan | 13 | $172 | $13 |
| Amlodipine Besylate | 19 | $154 | $8 |
| Lisinopril | 24 | $132 | $6 |
| Ibuprofen | 17 | $124 | $7 |
| Atorvastatin | 12 | $119 | $10 |
| Glimepiride | 15 | $99 | $7 |
| Metoprolol | 12 | $94 | $8 |
| Escitalopram | 12 | $66 | $5 |
| Clonazepam | 11 | $54 | $5 |
2015: 7 drugs
| Levothyroxine | 21 | $296 | $14 |
| Amlodipine Besylate | 18 | $169 | $9 |
| Simvastatin | 21 | $149 | $7 |
| Omeprazole | 15 | $141 | $9 |
| Lisinopril | 26 | $126 | $5 |
| Metformin | 20 | $120 | $6 |
| Escitalopram | 15 | $108 | $7 |
2014: 1 drug
| Trazodone | 13 | $97 | $7 |
Money from drug and device companies
$1,212 in 2025
| 2025 | 12 | 43 | None | $1,212 |
| 2024 | 10 | 53 | None | $1,466 |
| 2023 | 9 | 50 | None | $1,263 |
| 2022 | 12 | 38 | None | $712 |
| 2021 | 2 | 5 | None | $267 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Boehringer Ingelheim Pharmaceuticals | Jardiance | $382 | 6 payments
|
| Lilly USA | Mounjaro | $210 | 6 payments
|
| Bayer Healthcare Pharmaceuticals | Kerendia | $115 | 6 payments
|
| Dexcom | Dexcom G6 Transmitter | $83 | 4 payments
|
| ViiV Healthcare | Apretude | $82 | 5 payments
|
| Novo Nordisk | Rybelsus | $81 | 4 payments
|
See all 42 published payments
| Boehringer Ingelheim Pharmaceuticals | Meals · 2025-12-22 | Jardiance | $12 |
| Bayer Healthcare Pharmaceuticals | Meals · 2025-12-16 | Kerendia | $16 |
| Boehringer Ingelheim Pharmaceuticals | Meals · 2025-12-15 | Jardiance | $107 |
| Lilly USA | Meals · 2025-12-11 | Jardiance | $21 |
| Bayer Healthcare Pharmaceuticals | Meals · 2025-12-08 | Kerendia | $18 |
| Bayer Healthcare Pharmaceuticals | Meals · 2025-11-24 | Kerendia | $23 |
| Novo Nordisk | Meals · 2025-11-19 | Rybelsus | $20 |
| Bayer Healthcare Pharmaceuticals | Meals · 2025-11-15 | Kerendia | $14 |
| GlaxoSmithKline | Meals · 2025-11-05 | Shingrix | $19 |
| Exact Sciences | Meals · 2025-11-03 | None | $19 |
| Boehringer Ingelheim Pharmaceuticals | Meals · 2025-10-22 | Jardiance | $120 |
| Boehringer Ingelheim Pharmaceuticals | Meals · 2025-10-16 | Jardiance | $17 |
| Novo Nordisk | Meals · 2025-10-08 | Rybelsus | $19 |
| Dexcom | Meals · 2025-10-06 | Dexcom G6 Transmitter | $21 |
| Bayer Healthcare Pharmaceuticals | Meals · 2025-09-30 | Kerendia | $25 |
| Organon | Meals · 2025-09-23 | Nexplanon | $23 |
| Lilly USA | Meals · 2025-09-16 | None | $118 |
| ViiV Healthcare | Meals · 2025-09-10 | Apretude | $15 |
| Lilly USA | Meals · 2025-09-03 | Zepbound | $20 |
| ViiV Healthcare | Meals · 2025-08-26 | Apretude | $15 |
| Dexcom | Meals · 2025-08-25 | Dexcom G6 Transmitter | $21 |
| Exact Sciences | Meals · 2025-08-21 | The Cologuard Plus Collection Kit | $16 |
| Bayer Healthcare Pharmaceuticals | Meals · 2025-08-18 | Kerendia | $19 |
| Novo Nordisk | Meals · 2025-08-06 | Rybelsus | $24 |
| ViiV Healthcare | Meals · 2025-07-22 | Apretude | $16 |
| Dexcom | Meals · 2025-07-21 | Dexcom G6 Transmitter | $19 |
| Lilly USA | Meals · 2025-07-15 | Mounjaro | $19 |
| Novo Nordisk | Meals · 2025-07-09 | Rybelsus | $18 |
| Dexcom | Meals · 2025-06-16 | Dexcom G6 Transmitter | $21 |
| Medtronic | Meals · 2025-05-27 | Venaseal | $25 |
| Merck Sharp & Dohme | Meals · 2025-05-13 | Vaxelis | $26 |
| Viatris Specialty | Meals · 2025-05-07 | Yupelri | $21 |
| Lilly USA | Meals · 2025-04-08 | Mounjaro | $13 |
| Organon | Meals · 2025-03-24 | Nexplanon | $25 |
| Boehringer Ingelheim Pharmaceuticals | Meals · 2025-03-19 | Jardiance | $116 |
| ViiV Healthcare | Meals · 2025-03-14 | Apretude | $17 |
| ViiV Healthcare | Meals · 2025-03-07 | Apretude | $19 |
| Viatris Specialty | Meals · 2025-02-20 | Yupelri | $31 |
| Boehringer Ingelheim Pharmaceuticals | Meals · 2025-02-13 | Jardiance | $10 |
| Lilly USA | Meals · 2025-02-11 | Mounjaro | $18 |
| GlaxoSmithKline | Meals · 2025-02-06 | Shingrix | $28 |
| Viatris Specialty | Meals · 2025-01-29 | Yupelri | $27 |
See earlier years (2024, 2023, 2022, 2021)
2024: $1,466
| Novo Nordisk | Wegovy | $411 | 14 payments
|
| Lilly USA | Mounjaro | $377 | 12 payments
|
| Mylan Specialty L.P. | Yupelri | $293 | 12 payments
|
| ViiV Healthcare | Apretude | $205 | 6 payments
|
| Bayer Healthcare Pharmaceuticals | Kerendia | $65 | 3 payments
|
| Boehringer Ingelheim Pharmaceuticals | Jardiance | $33 | 1 payment
|
| Abbvie | Vraylar | $32 | 2 payments
|
| GlaxoSmithKline | Shingrix | $21 | 1 payment
|
| Pfizer | Paxlovid | $19 | 1 payment
|
| Organon | Nexplanon | $12 | 1 payment
|
2023: $1,263
| Novo Nordisk | Ozempic | $397 | 13 payments
|
| Boehringer Ingelheim Pharmaceuticals | Jardiance | $258 | 5 payments
|
| Lilly USA | Mounjaro | $196 | 13 payments
|
| Mylan Specialty L.P. | Yupelri | $181 | 7 payments
|
| AbbVie | Vraylar | $115 | 6 payments
|
| GlaxoSmithKline | Shingrix | $45 | 2 payments
|
| Amgen | Evenity | $37 | 2 payments
|
| Smith+Nephew | Collagenase Santyl | $20 | 1 payment
|
| Sanofi Pasteur | Menquadfi | $15 | 1 payment
|
2022: $712
| Novo Nordisk | Rybelsus | $142 | 8 payments
|
| Lilly USA | Trulicity | $131 | 11 payments
|
| Salix Pharmaceuticals a division of Bausch Health US | Xifaxan | $114 | 1 payment
|
| Abbvie | Vraylar | $57 | 4 payments
|
| Mylan Specialty L.P. | Yupelri | $57 | 3 payments
|
| Avanir Pharmaceuticals | Nuedexta | $46 | 2 payments
|
| Biohaven Pharmaceutical Holding Company | Nurtec Odt | $45 | 2 payments
|
| Merck Sharp & Dohme | Januvia | $38 | 2 payments
|
| Boehringer Ingelheim Pharmaceuticals | Jardiance | $27 | 2 payments
|
| Amgen | Evenity | $22 | 1 payment
|
| GlaxoSmithKline | Shingrix | $20 | 1 payment
|
| VBI Vaccines (Delaware) | Prehevbrio | $12 | 1 payment
|
2021: $267
| Novo Nordisk | Ozempic | $238 | 4 payments
|
| Mylan Specialty L.P. | Yupelri | $30 | 1 payment
|
Professional record
- NPI
- 1831484294
- Licence
- CA A128733California A128733: Current · expires 2027-03-31
- Gender
- Male
More record details
- Sole proprietor
- No
- Taxonomy
- Family medicine (207Q00000X)
- Mailing address
- 100 Wilson Rd Ste 100, Monterey, CA, 93940
- NPI first listed
- 2011-06-14
- NPI last updated
- 2025-02-25
- NPI record certified
- 2025-02-25
This is when the NPI record was last certified, not a medical board exam.
Extra NPI addresses: 9460 N Name Uno, Gilroy, CA, 95020 · 355 Abbott St Ste 100, Salinas, CA, 93901